International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(23), С. 12983 - 12983
Опубликована: Дек. 3, 2024
Nonmelanoma
skin
cancer
(NMSC)
presents
a
significant
challenge
to
global
healthcare
due
its
rising
incidence,
prompting
the
search
for
innovative
treatments
overcome
limitations
of
current
therapies.
Our
study
aims
explore
potential
effects
liquid
blood
concentrate
platelet-rich
fibrin
(PRF)
on
basal
cell
carcinoma
cells
(BCCs)
and
squamous
(SCCs)
in
order
obtain
results
that
may
lead
new
possible
adjunctive
therapies
managing
localized
cancers,
particularly
NMSC.
Basal
(BCC)
(SCC)
were
indirectly
treated
with
PRF
generated
via
different
relative
centrifugation
forces,
namely
high
low
RCF
PRF,
7
days.
PRF-treated
comparatively
analyzed
viability,
proliferation
cycle-
apoptosis-related
gene
expression.
Analysis
MTS
assay
revealed
decrease
viability
both
BCC
SCC
following
treatment
Ki-67
staining
showed
decreased
percentage
Ki-67-positive
after
2
days
compared
control
group.
The
downregulation
CCND1
expression
types
at
along
upregulation
p21
p53
demonstrated
effect
inhibiting
inducing
cycle
arrest,
especially
during
initial
phases
treatment.
Increased
caspase-8
caspase-9
was
observed,
indicating
activation
extrinsic
intrinsic
apoptotic
pathways
by
Although
exact
immunomodulatory
properties
require
further
investigation,
our
basic
vitro
studies
are
promising
might
provide
basis
future
investigations
as
an
therapy
IEEE photonics journal,
Год журнала:
2024,
Номер
16(2), С. 1 - 13
Опубликована: Март 27, 2024
non-melanoma
skin
cancer
(NMSC)
is
among
the
most
prevalent
forms
of
originating
in
top
layer
skin,
with
basal
cell
carcinoma
(BCC)
and
squamous
(SCC)
being
its
primary
categories.
While
both
types
are
highly
treatable,
success
treatment
hinges
on
early
diagnosis.
Early-stage
NMSC
detection
can
be
achieved
through
clinical
examination,
typically
involving
visual
inspection.
An
alternative,
albeit
invasive,
method
a
biopsy.
Microwave
imaging
has
gained
prominence
for
non-invasive
various
cancers,
leveraging
distinct
dielectric
properties
healthy
malignant
tissues
to
discriminate
tumors
categorize
them
as
benign
or
malignant.
Recent
studies
demonstrate
potential
terahertz
(THz)
spectroscopy
detecting
biomarkers
by
aligning
electromagnetic
wave
frequencies
low
THz
range
(0.1
10
THz)
resonant
biomolecules,
such
proteins.
This
study
proposes
an
innovative
microscale
biosensor
designed
operate
high-sensitivity
efficient
diagnosis
cancer.
By
incorporating
meticulously
metamaterial
layers,
sensor's
absorption
controlled,
critical
aspect
discriminating
between
normal
NMSC-affected
skin.
In
particular,
interaction
waves,
influenced
unique
vibrational
resonances
molecules
within
tissue,
crucial
propagation
scattering.
Extensive
numerical
showcased
suitability
proposed
diagnosis,
illustrated
specific
case
studies.
These
findings
hold
pave
way
further
development
microwave-imaging-based
techniques
other
Molecules,
Год журнала:
2024,
Номер
29(3), С. 728 - 728
Опубликована: Фев. 4, 2024
The
elevated
occurrence
of
non-melanoma
skin
cancer
(NMSC)
and
the
adverse
effects
associated
with
available
treatments
adversely
impact
quality
life
in
multiple
dimensions.
In
connection
this,
there
is
a
necessity
for
alternative
approaches
characterized
by
increased
tolerance
lower
side
effects.
Natural
compounds
could
be
employed
due
to
their
safety
profile
effectiveness
inflammatory
neoplastic
diseases.
These
anti-cancer
drugs
are
often
derived
from
natural
sources
such
as
marine,
zoonotic,
botanical
origins.
should
exhibit
anti-carcinogenic
actions
through
various
pathways,
influencing
apoptosis
potentiation,
cell
proliferation
inhibition,
metastasis
suppression.
This
review
provides
an
overview
used
chemotherapies,
chemoprevention,
promotion
regeneration,
including
polyphenolic
compounds,
flavonoids,
vitamins,
alkaloids,
terpenoids,
isothiocyanates,
cannabinoids,
carotenoids,
ceramides.
Future Journal of Pharmaceutical Sciences,
Год журнала:
2024,
Номер
10(1)
Опубликована: Март 27, 2024
Abstract
Background
Niosomes
hold
promise
as
drug
delivery
systems
for
cancer
treatment,
with
niosome
size
impacting
stability,
biodistribution,
and
effectiveness.
This
study
optimized
methotrexate
(MTX)-loaded
formulation
by
studying
the
effects
of
components
processing
conditions
on
size.
The
niosomes
was
made
thin-film
hydration
technique.
Results
(NIO
17)
a
6:2:2
ratio
span
60,
soya
PC,
cholesterol
achieved
55.05%
encapsulation,
particle
597.2
nm,
PDI
0.49,
zeta
potential
−
23.3
mV.
compatibility
lipids
confirmed
via
Fourier
transform
infrared
spectroscopy,
transmission
electron
microscopy
revealed
spherical,
well-dispersed
vesicles.
Differential
scanning
calorimetry
indicated
conversion
or
entrapment
within
In
vitro
release
exhibited
sustained
pattern
an
initial
burst.
NIO
17
showed
potent
anti-cancer
activity
against
B16-F10
cells
(GI50:
38.7176
μg/mL).
Ex
vivo
studies
suggest
tailoring
(597.2–982.3
nm)
to
target
specific
skin
depths
(0–38
μm)
enhanced
localized
delivery.
Conclusions
demonstrates
methotrexate-loaded
novel
therapy
approach,
highlighting
transdermal
17.
Further
research
is
necessary
explore
its
clinical
translation.
Graphical
abstract
Research Society and Development,
Год журнала:
2022,
Номер
11(10), С. e435111032984 - e435111032984
Опубликована: Авг. 6, 2022
O
câncer
de
pele
não
melanoma
(CPNM)
é
o
tipo
com
maior
incidência
e
tem
sido
classificado
em:
carcinoma
basocelular
(CBC)
espinocelular
(CEC).
objetivo
do
presente
estudo
foi
avaliar,
por
meio
uma
revisão
bibliográfica
integrativa,
a
utilização
lipossomas
no
diagnóstico
tratamento
CPNM.
A
estratégia
busca
dos
artigos
científicos
realizada
através
investigação
nas
bases
dados
Scopus,
Pubmed
Web
Of
Science,
acessando
Portal
Periódicos
Capes,
utilizando
os
descritores
em
inglês
“Liposomes”
AND
“non-melanoma”
“skin”
“cancer”
“(treatment
OR
diagnosis)”.
Para
auxiliar
processo
análise
artigos,
utilizou-se
plataforma
Rayyan.
Após
análise,
7
publicações
foram
selecionadas
para
compor
essa
revisão,
identificando:
títulos,
autores,
objetivos,
principais
resultados,
conclusões
temas
abordados
nos
estudos.
Observou-se
que
maioria
eixos
temáticos
abordaram
sistemas
lipossomais
potencialização
drogas
capacidade
antitumoral.
Os
demais
discorriam
sobre
na
detecção
das
lesões
associadas
ao
Câncer
Pele
Não
Melanoma
e,
também,
aplicação
nanocarreadores
terapias
anticâncer,
sobretudo
terapia
fotodinâmica.
Baseado
nisso,
concluiu-se
possuem
versátil
CPNM,
indo
diagnóstico,
entanto,
as
pesquisas
acerca
da
voltada
esse
tema,
são
escassas
recentes.
Dessa
forma,
esta
extrema
relevância
se
possa
direcionar
elaboração
novos
estudos
visem
aprimorar
técnicas
já
mencionadas
desenvolver
novas
tema.
Pharmaceutics,
Год журнала:
2023,
Номер
15(11), С. 2577 - 2577
Опубликована: Ноя. 3, 2023
Non-melanoma
skin
cancer
(NMSC)
is
the
most
prevalent
malignancy
worldwide,
with
approximately
6.3
million
new
cases
worldwide
in
2019.
One
of
key
management
strategies
for
NMSC
a
topical
treatment
usually
utilised
localised
and
early-stage
disease
owing
to
its
non-invasive
nature.
However,
efficacy
agents
often
hindered
by
poor
drug
penetration
patient
adherence.
Therefore,
various
research
groups
have
employed
advanced
delivery
systems,
including
patches
overcome
problem
conventional
treatments.
This
review
begins
an
overview
as
well
current
landscape
treatments
NMSC,
specifically
focusing
on
emerging
technology
patches.
A
detailed
discussion
their
potential
limitations
existing
therapies
will
then
follow.
Most
importantly,
best
our
knowledge,
this
work
unprecedentedly
combines
discusses
all
advancements
innovative
NMSC.
In
addition
this,
authors
present
insights
into
considerations
trends
construction
these
meant
researchers
clinicians
consider
utilising
patch
systems
clinical
trials
toward
interventions
Journal of Oncology Pharmacy Practice,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 24, 2025
Objective
Despite
the
reported
benefits
of
sunscreen
use
in
preventing
skin
cancer,
overall
protection
from
melanoma
and
non-melanoma
cancers
putatively
reflects
frequency
type.
Herein,
we
review
current
knowledge
regarding
sunscreen's
effectiveness
at
averting
development
cancers.
Data
sources
We
conducted
an
extensive
PubMed
search
comprising
several
articles
on
topic
prevention
with
specific
terms
that
included
usage,
side
effects.
summary
Several
observational,
cohort
studies
randomized
controlled
trials
have
underscored
forestalling
In
particular,
incidence
squamous-cell
carcinoma
is
reduced,
although
effect
basal-cell
relatively
less
pronounced.
Conclusions
The
implications
this
study
indicate
reduces
deriving
intended
contingent
upon
type
adherence
to
recommended
guidelines.
primary
effects
include
dermal
irritation
rash;
since
there
some
indication
UV
filter-based
sunscreens
may
harbor
carcinogenic
properties,
clinicians
should
advise
their
patients
sunscreen,
not
mention
use.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Май 1, 2025
Non-melanoma
skin
cancers
(NMSCs),
including
basal
cell
carcinoma
(BCC)
and
squamous
(SCC),
have
shown
significant
global
increases
in
burden,
particularly
among
older
adults,
with
wide
regional,
gender,
socio-demographic
disparities.
However,
no
previous
study
has
comprehensively
analyzed
these
trends
using
integrated
multi-model
approaches.
A
comprehensive
analysis
of
non-melanoma
cancer
(NMSC)
data
from
1990
to
2021
was
performed,
trend
analysis,
frontier
decomposition
compare
the
burden
(SCC)
across
regions,
genders,
groups.
Temporal
incidence,
prevalence,
disability-adjusted
life
years
(DALYs)
were
identified
epidemiological
techniques.
To
forecast
future
disease
2022
2050,
eight
machine
learning
models
(Prophet,
ARIMA,
TBATS,
ElasticNet,
ETS,
VAR,
HoltWinters,
Theta)
applied,
most
optimal
predictive
for
BCC
SCC
selected
based
on
performance
metrics.
From
2021,
adults
increased
substantially.
The
incidence
rose
by
291.85%,
an
age-standardized
rate
(ASR)
increase
62.79%,
while
322.77%,
a
67.42%
rise
ASR.
High
Socio-Demographic
Index
(SDI)
regions
showed
largest
ASR
(102.73%)
(107.31%),
whereas
low
SDI
demonstrated
more
modest
changes
or
declines
(BCC:
-
2.86%,
SCC:
3.08%).
Gender
disparities
observed,
males
accounting
56.47%
cases
globally.
Decomposition
revealed
that
population
growth
primary
driver
NMSC
contributing
62.52-83.92%
DALYs,
accounted
up
52.2%
high
regions.
Frontier
highlighted
regional
disparities,
such
as
North
America,
exhibiting
highest
rates
(2,923.22
per
100,000)
(1,805.33
100,000),
like
sub-Saharan
Africa,
minimal
burdens
near
values.
Finally,
forecasting
2050
predicted
slight
decrease
(from
314.00
308.73
157.67
148.16
100,000).
Disability-adjusted
are
projected
decline
(79.32
75.20
but
slightly
(0.136
0.151
These
projections
underscore
need
tailored
strategies
address
growing
NMSC.
NMSCs,
underscores
urgent
prevention,
resource
allocation,
management
strategies.
Machine
learning-based
approaches
provide
robust
insights
into
challenges
SCC.